Literature DB >> 21606305

Abdominal ultrasound with scintigraphic and clinical correlates in infants with sickle cell anemia: baseline data from the BABY HUG trial.

M Beth McCarville1, Zhaoyu Luo, Xiangke Huang, Renee C Rees, Zora R Rogers, Scott T Miller, Bruce Thompson, Ram Kalpatthi, Winfred C Wang.   

Abstract

OBJECTIVE: The purpose of this study is to perform and evaluate baseline abdominal ultrasound in infants with sickle cell anemia who participated in the BABY HUG multiinstitutional randomized placebo-controlled trial of hydroxyurea therapy and to examine the potential relationships among ultrasound results and clinical, nuclear medicine, and laboratory data. SUBJECTS AND METHODS: After local institutional review board approval and with informed guardian consent, 116 girls and 87 boys (age range, 7.5-18 months) with sickle cell anemia underwent standardized abdominal sonography at 14 institutions. Imaging was centrally reviewed by one radiologist who assessed and measured the spleen, kidneys, gallbladder, and common bile duct. Baseline physical assessment of spleen size, serum alanine aminotransferase and bilirubin levels, (99m)Tc sulfur colloid liver-spleen scans, and (99m)Tc diethylenetriaminepentaacetic acid clearance glomerular filtration rates (GFRs) were obtained. Analysis of variance and the Student test were performed to compare sonographic findings to published results in healthy children and to clinical and laboratory findings.
RESULTS: The mean (± SD) spleen volume (108 ± 47 mL) was significantly greater than published normal control values (30 ± 14 mL; p < 0.0001). There was no correlation between spleen volume and function assessed by liver-spleen scan. The mean GFR (125 ± 34 mL/min/1.73 m(2)) was elevated compared with control GFRs (92 ± 18 mL/min/1.73 m(2)). Renal volumes (right kidney, 29 ± 8 mL; left kidney, 31 ± 9 mL) were significantly greater than control volumes (right kidney, 27 ± 3 mL; left kidney, 27 ± 3 mL; p < 0.0001) and were positively correlated with GFR (p = 0.0009). Five percent of patients had sonographic biliary abnormalities (sludge, n = 6; dilated common bile duct, n = 2; and cholelithiasis and thickened gallbladder wall, n = 1 each). There was no correlation between biliary sonographic findings and laboratory results.
CONCLUSION: In infants with sickle cell anemia, sonographic spleen volume does not reflect function, but increased renal volume correlates with GFR and is consistent with hyperfiltration. Sonographic biliary abnormalities can occur early in life, while remaining clinically silent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606305      PMCID: PMC4699671          DOI: 10.2214/AJR.10.4664

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  34 in total

1.  A histologic appraisal of the kidney in sickle cell anemia.

Authors:  J BERNSTEIN; C F WHITTEN
Journal:  Arch Pathol       Date:  1960-10

2.  The kidney in sickle cell anemia.

Authors:  G A Alleyne
Journal:  Kidney Int       Date:  1975-06       Impact factor: 10.612

3.  Total parenteral nutrition (TPN) and gallbladder diseases in neonates. Sonographic assessment.

Authors:  C Matos; E F Avni; D Van Gansbeke; A Pardou; J Struyven
Journal:  J Ultrasound Med       Date:  1987-05       Impact factor: 2.153

4.  Early renal changes in sickle cell anemia.

Authors:  J A Pitcock; E E Muirhead; F E Hatch; J G Johnson; B J Kelly
Journal:  Arch Pathol       Date:  1970-11

5.  Kidney size in childhood. Sonographical growth charts for kidney length and volume.

Authors:  E Dinkel; M Ertel; M Dittrich; H Peters; M Berres; H Schulte-Wissermann
Journal:  Pediatr Radiol       Date:  1985

6.  Post-natal decline of fetal haemoglobin in homozygous sickle cell disease: relationship to parenteral Hb F levels.

Authors:  K P Mason; Y Grandison; R J Hayes; B E Serjeant; G R Serjeant; S Vaidya; W G Wood
Journal:  Br J Haematol       Date:  1982-11       Impact factor: 6.998

7.  Cholelithiasis in patients with major sickle hemoglobinopathies.

Authors:  M B Rennels; M G Dunne; N J Grossman; A D Schwartz
Journal:  Am J Dis Child       Date:  1984-01

8.  Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial.

Authors:  Zora R Rogers; Winfred C Wang; Zhaoyu Luo; Rathi V Iyer; Eglal Shalaby-Rana; Stephen D Dertinger; Barry L Shulkin; John H Miller; Bea Files; Peter A Lane; Bruce W Thompson; Scott T Miller; Russell E Ware
Journal:  Blood       Date:  2011-01-07       Impact factor: 22.113

9.  The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.

Authors:  Bruce W Thompson; Scott T Miller; Zora R Rogers; Renee C Rees; Russell E Ware; Myron A Waclawiw; Rathi V Iyer; James F Casella; Lori Luchtman-Jones; Sohail Rana; Courtney D Thornburg; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada Sarnaik; Thomas H Howard; Lori Luck; Winfred C Wang
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

Review 10.  The spleen in the sickling disorders: an update.

Authors:  Rana Khatib; Raja Rabah; Sharada A Sarnaik
Journal:  Pediatr Radiol       Date:  2008-11-11
View more
  8 in total

Review 1.  Sickle cell disease: renal manifestations and mechanisms.

Authors:  Karl A Nath; Robert P Hebbel
Journal:  Nat Rev Nephrol       Date:  2015-02-10       Impact factor: 28.314

Review 2.  Interventions for chronic kidney disease in people with sickle cell disease.

Authors:  Noemi Ba Roy; Patricia M Fortin; Katherine R Bull; Carolyn Doree; Marialena Trivella; Sally Hopewell; Lise J Estcourt
Journal:  Cochrane Database Syst Rev       Date:  2017-07-03

3.  Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.

Authors:  Ofelia Alvarez; Scott T Miller; Winfred C Wang; Zhaoyu Luo; M Beth McCarville; George J Schwartz; Bruce Thompson; Thomas Howard; Rathi V Iyer; Sohail R Rana; Zora R Rogers; Sharada A Sarnaik; Courtney D Thornburg; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2012-01-31       Impact factor: 3.167

4.  Effects of chronic transfusions on abdominal sonographic abnormalities in children with sickle cell anemia.

Authors:  Mary Beth McCarville; Zora R Rogers; Sharada Sarnaik; Paul Scott; Banu Aygun; Lee Hilliard; Margaret T Lee; Karen Kalinyak; William Owen; Julian Garro; William Schultz; Nancy Yovetich; Russell E Ware
Journal:  J Pediatr       Date:  2011-09-09       Impact factor: 4.406

5.  Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG Trial.

Authors:  Zora R Rogers; Winfred C Wang; Zhaoyu Luo; Rathi V Iyer; Eglal Shalaby-Rana; Stephen D Dertinger; Barry L Shulkin; John H Miller; Bea Files; Peter A Lane; Bruce W Thompson; Scott T Miller; Russell E Ware
Journal:  Blood       Date:  2011-01-07       Impact factor: 22.113

Review 6.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Angela E Rankine-Mullings; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2022-09-01

Review 7.  Clinical management of sickle cell liver disease in children and young adults.

Authors:  Eirini Kyrana; David Rees; Florence Lacaille; Emer Fitzpatrick; Mark Davenport; Nigel Heaton; Sue Height; Marianne Samyn; Fulvio Mavilio; Valentine Brousse; Abid Suddle; Subarna Chakravorty; Anita Verma; Girish Gupte; Marki Velangi; Baba Inusa; Emma Drasar; Nedim Hadzic; Tassos Grammatikopoulos; Jonathan Hind; Maesha Deheragoda; Maria Sellars; Anil Dhawan
Journal:  Arch Dis Child       Date:  2020-11-11       Impact factor: 3.791

Review 8.  Hydroxyurea (hydroxycarbamide) for sickle cell disease.

Authors:  Sarah J Nevitt; Ashley P Jones; Jo Howard
Journal:  Cochrane Database Syst Rev       Date:  2017-04-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.